Inflammation-induced changes in the pharmacokinetics and dynamics of numerous drugs have been reported. Altered drug disposition during inflammatory disease has traditionally been ascribed primarily to changes in drug metabolism and protein binding. Emerging evidence within the last decade, however, has demonstrated that the inflammatory response affects the expression of several important drug transporters and these changes significantly impact the disposition and activity of drug substrates.
No takes yet. Share an insight, caveat, or question.
Petrović et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: